Skip header and navigation

1 records – page 1 of 1.

The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort.

https://arctichealth.org/en/permalink/ahliterature120514
Source
BMC Musculoskelet Disord. 2012;13:179
Publication Type
Article
Date
2012
Author
Mary-Ann Fitzcharles
Peter A Ste-Marie
Pantelis Panopalis
Henri Ménard
Yoram Shir
Fred Wolfe
Author Affiliation
Division of Rheumatology, McGill University, Montreal, Canada. mary-ann.fitzcharles@muhc.mcgill.ca
Source
BMC Musculoskelet Disord. 2012;13:179
Date
2012
Language
English
Publication Type
Article
Keywords
Adult
Comprehension
Disability Evaluation
Female
Fibromyalgia - diagnosis - epidemiology - physiopathology - psychology
Health Surveys
Humans
Language
Male
Middle Aged
Pain Measurement
Predictive value of tests
Quality of Life
Quebec - epidemiology
Questionnaires
Reproducibility of Results
Severity of Illness Index
Abstract
Fibromyalgia (FM) is a pain condition with associated symptoms contributing to distress. The Fibromyalgia Survey Diagnostic Criteria and Severity Scale (FSDC) is a patient-administered questionnaire assessing diagnosis and symptom severity. Locations of body pain measured by the Widespread Pain Index (WPI), and the Symptom Severity scale (SS) measuring fatigue, unrefreshing sleep, cognitive and somatic complaints provide a score (0-31), measuring a composite of polysymptomatic distress. The reliability and validity of the translated French version of the FSDC was evaluated.
The French FSDC was administered twice to 73 FM patients, and was correlated with measures of symptom status including: Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire (HAQ), McGill Pain Questionnaire (MPQ), and a visual analogue scale (VAS) for global severity and pain. Test-retest reliability, internal consistency, and construct validity were evaluated.
Test-retest reliability was between .600 and .888 for the 25 single items of the FSDC, and .912 for the total FSDC, with all correlations significant (p?
Notes
Cites: Qual Life Res. 2002 Sep;11(6):583-9212206579
Cites: PM R. 2012 Apr;4(4):257-6322541373
Cites: Arthritis Rheum. 1980 Feb;23(2):137-457362664
Cites: Acta Psychiatr Scand. 1983 Jun;67(6):361-706880820
Cites: Arch Phys Med Rehabil. 1987 Jul;68(7):438-413606368
Cites: Arthritis Rheum. 1990 Feb;33(2):160-722306288
Cites: Res Nurs Health. 1990 Aug;13(4):227-362197679
Cites: J Rheumatol. 1991 May;18(5):728-331865419
Cites: Clin J Pain. 1993 Sep;9(3):189-958219519
Cites: J Clin Epidemiol. 1993 Dec;46(12):1417-328263569
Cites: J Rheumatol Suppl. 2005 Aug;75:22-816078357
Cites: J Rheumatol. 2006 Sep;33(9):1863-516924687
Cites: Rheumatology (Oxford). 2006 Nov;45(11):1409-1516621922
Cites: Rheum Dis Clin North Am. 2009 May;35(2):329-3719647146
Cites: Arthritis Res Ther. 2009;11(4):R12019664287
Cites: Arthritis Care Res (Hoboken). 2010 May;62(5):583-420461781
Cites: Arthritis Care Res (Hoboken). 2010 May;62(5):600-1020461783
Cites: J Rheumatol. 2011 Jun;38(6):1113-2221285161
Cites: Mod Rheumatol. 2012 Feb;22(1):40-421556970
Cites: Pain. 1975 Sep;1(3):277-991235985
PubMed ID
22994975 View in PubMed
Less detail